Advertisement

Transplantation of Newborn Brain Tissue into Adult Kainic-Acid-Lesioned Neostriatum

  • P. L. McGeer
  • H. Kimura
  • E. G. McGeer

Abstract

Other chapters in this volume detail many of the studies that have so far been performed indicating that transplanted tissue can survive in host brain and that it is immunologically privileged, apparently because it lies behind the blood-brain barrier.

Keywords

Kainic Acid Cresyl Violet Striatal Tissue Cresyl Violet Staining Host Brain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McGeer, P. L., McGeer, E. G., and Hattori, T., 1978, Kainic acid as a tool in neurobiology, in: Kainic Acid as a Tool in Neurobiology (E. G. McGeer, J. W. Olney, and P. L. McGeer, eds.), pp. 123–138, Raven Press, New York.Google Scholar
  2. 2.
    Coyle, J. T., McGeer, E. G., McGeer, P. L., and Schwarcz, R., 1978, Neostriatal injections: A model for Huntington’s chorea, in: Kainic Acid as a Tool in Neurobiology (E. G. McGeer, J. W. Olney, and P. L. McGeer, eds.), pp. 139–160, Raven Press, New York.Google Scholar
  3. 3.
    Zaczek, R., Schwarcz, R., and Coyle, J. T., 1978, Long-term sequelae of striatal kainate lesion, Brain Res. 152:626.PubMedCrossRefGoogle Scholar
  4. 4.
    Sperk, G., and Schlogl, E., 1979, Reduction of number of benzodiazepine binding sites in the caudate nucleus of the rat after kainic acid injections, Brain Res. 170:563.PubMedCrossRefGoogle Scholar
  5. 5.
    Mohler, H., and Okada, T., 1978, The benzodiazepine receptor in normal and pathological human brain, Br. J. Psychiatry 133: 261.PubMedCrossRefGoogle Scholar
  6. 6.
    Fields, J. Z., Reisine, T. D., and Yamamura, H. I., 1978, Loss of striatal dopaminergic receptors after intrastriatal kainic acid, Life Sci. 23:569.PubMedCrossRefGoogle Scholar
  7. 7.
    Schwarcz, R., Fuxe, K., Hokfelt, T., Terenius, L., and Goldstein, M., 1980, Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia, J. Neurochem. 34:772.PubMedCrossRefGoogle Scholar
  8. 8.
    Weinreich, P., and Seeman, P., 1980, Effect of kainic acid on striatal dopamine receptors, Brain Res. 198:491.PubMedCrossRefGoogle Scholar
  9. 9.
    Fillion, G., Beaudoin, D., Rousselle, J. C., Deniau, J. M., Fillion, M. P., Dray, F., and Jacob, J., 1979, Decrease of [3H]-5-HT high affinity binding and 5-HT adenylate cyclase activation after kainic acid lesion in rat brain striatum, J. Neurochem. 33:567.PubMedCrossRefGoogle Scholar
  10. 10.
    Vincent, S. R., and McGeer, E. G., 1979, Kainic acid binding to membranes of striatal neurons, Life Sci. 24:265.PubMedCrossRefGoogle Scholar
  11. 11.
    Henke, H., 1979, Kainic acid binding in human caudate nucleus: Effect of Huntington’s disease, Neurosci. Lett. 14:247.PubMedCrossRefGoogle Scholar
  12. 12.
    Beaumont, K., Maurin, Y., Reisine, T. D., Fields, J. Z., Spokes, E., Bird, E. D., and Yamamura, H. I., 1979, Huntington’s disease and its animal model: Alterations in kainic acid binding, Life Sci. 24:809.PubMedCrossRefGoogle Scholar
  13. 13.
    London, E. D., Yamamura, H. I., Bird, E. D., and Coyle, J. T., 1981, Decreased receptor-binding sites for kainic acid in brains of patients with Huntington’s disease, Biol. Psychiatry 16:155.PubMedGoogle Scholar
  14. 14.
    Neckers, L. M., Neff, N. H., and Wyatt, R. J., 1979, Increased serotonin turnover in corpus striatum following an injection of kainic acid: Evidence for neuronal feedback regulation of synthesis, Naunyn-Schmiedebergs Arch. Pharmacol. 306:173.PubMedCrossRefGoogle Scholar
  15. 15.
    Zahniser, N. R., Minneman, K. P., and Molinoff, P. B., 1979, Persistence of β-adrenergic receptors in rat striatum following kainic acid administration, Brain Res. 178:589.PubMedCrossRefGoogle Scholar
  16. 16.
    Enna, S. J., Bird, E. D., Bennett, J. P., Bylund, D. B., Yamamura, H. I., Iversen, L. L., and Snyder, S., 1976, Huntington’s chorea: Changes in neurotransmitter receptors in the brain, N. Engl. f. Med. 294:1305.CrossRefGoogle Scholar
  17. 17.
    Spindel, E. R., Wurtman, R. J., and Bird, E. D., 1980, Increased TRH content of the basal ganglia in Huntington’s disease, N. Engl. J. Med. 303:1235.PubMedGoogle Scholar
  18. 18.
    Spindel, E. R., Pettibone, D. J., and Wurtman, R. J., 1981, Thyrotropin-releasing hormones (TRH) content of rat striatum: Modification by drugs and lesions, Brain Res. 216:323.PubMedCrossRefGoogle Scholar
  19. 19.
    Higatsberger, M. R., Sperk, G., Bernheimer, H., Shannak, K. S., and Hornykiewicz, O., 1981, Striatal ganglioside levels in the rat following kainic acid lesions: Comparison with Huntington’s disease, Exp. Brain Res. 44:93.PubMedCrossRefGoogle Scholar
  20. 20.
    Ando, N., Gold, B. I., Bird, E. D., and Roth, R. H., 1979, Regional brain levels of γ-hydroxybutyrate in Huntington’s disease, J. Neurochem. 32:617.PubMedCrossRefGoogle Scholar
  21. 21.
    Ando, N., Simon, J. R., and Roth, R. H., 1979, Inverse relationship between GABA and γ-hydroxybutyrate levels in striatum of rat injected with kainic acid, J. Neurochem. 32:623.PubMedCrossRefGoogle Scholar
  22. 22.
    Wong, P. T.-H., McGeer, E. G., and McGeer, P. L., 1982, Effects of kainic acid injection and cortical lesion on ornithine and aspartate aminotransferases in rat striatum, J. Neurosci. Res. 8: 643–650.PubMedCrossRefGoogle Scholar
  23. 23.
    Wong, P., T.-H., McGeer, P. L., Rossor, M., and McGeer, E. G., 1982, Ornithine aminotransferase in Huntington’s disease, Brain Res. 231:466.PubMedCrossRefGoogle Scholar
  24. 24.
    Cross, A. J., and Waddington, J. L., 1981, Substantia nigra γ-aminobutyric acid receptors in Huntington’s disease, J. Neurochem. 37:321.PubMedCrossRefGoogle Scholar
  25. 25.
    Waddington, J. L., and Cross, A. J., 1980, The striatonigral GABA pathway: Functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions, Eur. J. Pharmacol. 67:27.PubMedCrossRefGoogle Scholar
  26. 26.
    Emson, D. C., Rehfeld, J. F., Langvin, H., and Rossor, M., 1980, Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington’s disease, Brain Res. 198:497.PubMedCrossRefGoogle Scholar
  27. 27.
    Sokoloff, L., Reivich, M., Kennedy, C., Des Rosiers, M. H., Patlak, G. S., Pettigrew, K. D., Sakurada, O., and Shinohara, M., 1977, The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat, J. Neurochem. 28:897.PubMedCrossRefGoogle Scholar
  28. 28.
    McGeer, E. G., McGeer, P. L., Hattori, T., and Vincent, S. R., 1979, Kainic acid neurotoxicity and Huntington’s disease, Adv. Neurol. 23:577.Google Scholar
  29. 29.
    Kimura, H., McGeer, E. G., and McGeer, P. L., 1980, Metabolic alterations in an animal model of Huntington’s disease using the 14C-deoxyglucose method, J. Neurol. Transmiss. Suppl. 16: 103.Google Scholar
  30. 30.
    Jacubovic, A., Lin, D., and McGeer, E. G., 1979, Protein and RNA synthesis in kainic acid injected striata, Brain Res. 163:289.CrossRefGoogle Scholar
  31. 31.
    Schmidt, R. H., Björklund, A., and Stenevi, U., 1981, Intracerebral grafting of dissociated CNS tissue suspensions: A new approach for neuronal transplantation to deep brain sites, Brain Res. 218:347.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • P. L. McGeer
    • 1
  • H. Kimura
    • 1
  • E. G. McGeer
    • 1
  1. 1.Kinsmen Laboratory of Neurological Research, Department of PsychiatryUniversity of British ColumbiaVancouverCanada

Personalised recommendations